Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Schirripa

Showing results (11-20 of 98) with videos related to

Pageof 10
Sort By:
Recenti Progressi in Medicina|January 22, 2026
[CHALLENGE accepted! Exercise in oncology: from "Supportive Care" to "Effective Treatment".]Aureliano Stingi, Giuseppe Aprile, Sara Aspromonte, et al.
Journal of Cancer Metastasis and Treatment|September 17, 2021
Pharmacogenomics in colorectal cancer: current role in clinical practice and future perspectivesFrancesca Battaglin, Alberto Puccini, Madiha Naseem, et al.
European Journal of Cancer (Oxford, England : 1990)|May 24, 2020
Thyroid hormones ratio is a major prognostic marker in advanced metastatic colorectal cancer: Results from the phase III randomised CORRECT trialGiuseppe Pasqualetti, Marta Schirripa, Emmanuelle Dochy, et al.
Cancer Genomics & Proteomics|April 24, 2021
Potential Molecular Cross Talk Among CCR5 Pathway Predicts Regorafenib Responsiveness in Metastatic Colorectal Cancer PatientsMitsukuni Suenaga, W U Zhang, Tetsuo Mashima, et al.
Biomed Research International|August 1, 2017
Immunotherapy in Gastrointestinal CancersLetizia Procaccio, Marta Schirripa, Matteo Fassan, et al.
Cancer|October 20, 2011
Clinical impact of anti-epidermal growth factor receptor monoclonal antibodies in first-line treatment of metastatic colorectal cancer: meta-analytical estimation and implications for therapeutic strategiesFotios Loupakis, Chiara Cremolini, Lisa Salvatore, et al.
Pharmacogenetics and Genomics|August 1, 2020
Role of enterocyte-specific gene polymorphisms in response to adjuvant treatment for stage III colorectal cancerMitsukuni Suenaga, Shu Cao, Wu Zhang, et al.
Tumori|June 30, 2020
Outcome of patients with colorectal cancer undergoing lung metastases resection: a single-institution retrospective analysisMarco Mammana, Francesca Bergamo, Letizia Procaccio, et al.
Cancer Cell International|February 5, 2020
The heterogeneous clinical and pathological landscapes of metastatic <i>Braf</i>-mutated colorectal cancerGiuseppe Nicolò Fanelli, Carlo Alberto Dal Pozzo, Ilaria Depetris, et al.
International Journal of Cancer|November 10, 2018
Genetic variants in CCL5 and CCR5 genes and serum VEGF-A levels predict efficacy of bevacizumab in metastatic colorectal cancer patientsMitsukuni Suenaga, Shu Cao, Wu Zhang, et al.
Pageof 10

Showing results (11-20 of 98) with videos related to

Sort By:
Pageof 10
Recenti Progressi in Medicina|January 22, 2026
[CHALLENGE accepted! Exercise in oncology: from "Supportive Care" to "Effective Treatment".]Aureliano Stingi, Giuseppe Aprile, Sara Aspromonte, et al.
Journal of Cancer Metastasis and Treatment|September 17, 2021
Pharmacogenomics in colorectal cancer: current role in clinical practice and future perspectivesFrancesca Battaglin, Alberto Puccini, Madiha Naseem, et al.
European Journal of Cancer (Oxford, England : 1990)|May 24, 2020
Thyroid hormones ratio is a major prognostic marker in advanced metastatic colorectal cancer: Results from the phase III randomised CORRECT trialGiuseppe Pasqualetti, Marta Schirripa, Emmanuelle Dochy, et al.
Cancer Genomics & Proteomics|April 24, 2021
Potential Molecular Cross Talk Among CCR5 Pathway Predicts Regorafenib Responsiveness in Metastatic Colorectal Cancer PatientsMitsukuni Suenaga, W U Zhang, Tetsuo Mashima, et al.
Biomed Research International|August 1, 2017
Immunotherapy in Gastrointestinal CancersLetizia Procaccio, Marta Schirripa, Matteo Fassan, et al.
Cancer|October 20, 2011
Clinical impact of anti-epidermal growth factor receptor monoclonal antibodies in first-line treatment of metastatic colorectal cancer: meta-analytical estimation and implications for therapeutic strategiesFotios Loupakis, Chiara Cremolini, Lisa Salvatore, et al.
Pharmacogenetics and Genomics|August 1, 2020
Role of enterocyte-specific gene polymorphisms in response to adjuvant treatment for stage III colorectal cancerMitsukuni Suenaga, Shu Cao, Wu Zhang, et al.
Tumori|June 30, 2020
Outcome of patients with colorectal cancer undergoing lung metastases resection: a single-institution retrospective analysisMarco Mammana, Francesca Bergamo, Letizia Procaccio, et al.
Cancer Cell International|February 5, 2020
The heterogeneous clinical and pathological landscapes of metastatic <i>Braf</i>-mutated colorectal cancerGiuseppe Nicolò Fanelli, Carlo Alberto Dal Pozzo, Ilaria Depetris, et al.
International Journal of Cancer|November 10, 2018
Genetic variants in CCL5 and CCR5 genes and serum VEGF-A levels predict efficacy of bevacizumab in metastatic colorectal cancer patientsMitsukuni Suenaga, Shu Cao, Wu Zhang, et al.
Pageof 10